Contraceptive methods after gynecological and breast cancer;Contraception après cancer gynécologique et mammaire

Bulletin de l'Academie Nationale de Medecine

Volumn 194, Issue 3, 2010, Pages 521-527

  Blanc, Bernard ^b   Lazard, Alexandre ^a   Estrade, Jean Philippe ^b   Agostini, Aubert ^a   Gurriet, Brice ^b  

^a HÔPITAL DE LA CONCEPTION   (France)

^b Hospital Ambroise Pare   (France)

Author keywords

Breast neoplasms; Contraception; Urogenital neoplasms

Indexed keywords

EID: 77958550313     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32293-9     Document Type: Article

References (12)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives : further results. Contraception, 1996.54 (3 Suppl), p. 1S-106S.
2. HANKINSON S.E. et al. -A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States). Cancer Causes Control, 1997, 8(1), p. 65-72.
3. URSIN G. et al. - Use of oral contraceptives and risk of breast cancer in young women. Breast Cancer Res Treat., 1998. 50(2), p. 175-84.
4. MARCHBANKS P.A. et al.- Oral contraceptives and the risk of breast cancer. N Engl. J. Med, 2002, 346(26), p. 2025-32.
5. CLAUS E.B., STOWE M., CARTER D.- Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Res. Treat., 2003 Sep., 81(2), 129-36.
6. NAROD S.A. et al.- Oral contraceptives and the risk of breast cancer in BRCAl and BRCA2 mutation carriers. J. Natl. Cancer Inst., 2002, 94(23), p. 1773-9.
7. GRENADER T., PERETZ T., LIFCKTZ M., SHA VIT L.- BRCAl and BRCA2 germ-line mutation and oral contraceptives : to use or not to use. Breast. 2005, Aug, 14(4), 264-8. Review.
8. EISINGER F. et al. - [Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)]. Bull. Cancer, 2004, 91(3), p. 219-37.
9. MCLAUGHLIN J.R. et al.- Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations : a case-control study. Lancet Oncol, 2007, 8(1), p. 26-34.
10. SKEGG D.C., PAUL C., SPEARS G.F., WILLIAMS S.M. - Progestogen only oral contraceptivess and risk of breast cancer, in new Zealand. Cancer Causes Control. 1996, Sep. 7(5), 513-9.
11. BOUTET G. - Dispositif intra-utérin au lévonorgestrel (Mirena) et cancer du sein. Gynecol. Obstet. Fertil, 2006, 34, 1015-23.
12. SMITH, J.S. et al - Cervical cancer and use of hormonal contraceptives : a systematic review. Lancet, 2003, 361(9364), p. 1159-67.